| scholarly article | Q13442814 |
| P50 | author | José Miguel Carrasco | Q56074814 |
| Adela Castelló | Q56879079 | ||
| María Victoria Hernández | Q57951336 | ||
| Ricardo Blanco | Q73343789 | ||
| P2093 | author name string | Miguel Reyes | |
| Miguel Cordero-Coma | |||
| Alex Fonollosa | |||
| Cruz Fernández-Espartero | |||
| David Diaz-Valle | |||
| Elia Valls | |||
| Emma Beltran-Catalán | |||
| Esperanza Pato | |||
| Félix Francisco | |||
| Fernando Sanchez-Alonso | |||
| Laura Pelegrin | |||
| Lucia Martinez-Costa | |||
| Mª Auxiliadora Martin-Martinez | |||
| Mar Esteban | |||
| Marisa Hernández-Garfella | |||
| Rosalía Méndez-Fernandez | |||
| Santiago Muñoz-Fernández | |||
| Teresa Diaz-Valle | |||
| P2860 | cites work | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | Q24727581 |
| Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis | Q26796779 | ||
| Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). | Q33442294 | ||
| Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score | Q33563148 | ||
| Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis | Q34127750 | ||
| A simulation study of the number of events per variable in logistic regression analysis | Q34411363 | ||
| Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography | Q35570770 | ||
| Advances in the diagnosis and immunotherapy for ocular inflammatory disease | Q37102197 | ||
| Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation | Q37128454 | ||
| Causes and frequency of blindness in patients with intraocular inflammatory disease | Q37319691 | ||
| Understanding uveitis: the impact of research on visual outcomes | Q37909585 | ||
| Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. | Q37995987 | ||
| Role of OCT in the diagnosis and management of macular edema from uveitis | Q38060801 | ||
| Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis | Q38495949 | ||
| Receiver operating characteristic (ROC) methodology: the state of the art. | Q38671388 | ||
| OMERACT: an international initiative to improve outcome measurement in rheumatology | Q41913289 | ||
| Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience | Q43728566 | ||
| Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates | Q43796813 | ||
| Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy | Q44234976 | ||
| The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques | Q44635152 | ||
| Comparison of quantitative diagnostic tests: type I error, power, and sample size | Q47198136 | ||
| Spectral-domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors | Q47897078 | ||
| Adalimumab in Patients with Active Noninfectious Uveitis. | Q49025036 | ||
| Development of a disease activity score based on judgment in clinical practice by rheumatologists. | Q52399756 | ||
| Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. | Q52870118 | ||
| Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. | Q53212276 | ||
| Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. | Q53606178 | ||
| Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity. | Q54289137 | ||
| International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease | Q69741243 | ||
| Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy | Q72193667 | ||
| Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center | Q74258850 | ||
| Impact of macular edema on visual acuity in uveitis | Q80023608 | ||
| Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis | Q83968976 | ||
| Standardization of vitreal inflammatory activity in intermediate and posterior uveitis | Q93559746 | ||
| Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials | Q95483222 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | uveitis | Q280027 |
| P304 | page(s) | 647-656 | |
| P577 | publication date | 2016-11-04 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Development of an activity disease score in patients with uveitis (UVEDAI). | |
| P478 | volume | 37 |
| Q98771808 | Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study |
| Q51752440 | Comparison of corneal endothelial cell analysis in patients with uveitis and healthy subjects. |
| Q90422414 | Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Child |
Search more.